Quantification of PET Amyloid and Tau Ligand [F-18]FDDNP in early Alzheimer disease

被引：0
|
作者：
Tauber, C. [1 ]
Vercouillie, J. [1 ]
Kepe, V. [2 ]
Beaufils, E. [3 ]
Venel, Y. [3 ]
Baulieu, J. [3 ]
Gendre, D. [4 ]
Barrio, J. [2 ]
Cottier, J. [3 ]
Mondon, K. [3 ]
Hommet, C. [3 ]
Camus, V. [3 ]
Guilloteau, D. [5 ]
机构：
[1] Univ Tours, UMRS INSERM U930, CNRS ERL3106, Tours, France
[2] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, D Geffen Sch Med, Los Angeles, CA USA
[3] Hop Bretonneau, CHRU Tours, Tours, France
[4] Ctr Invest Clin CIC U202, Tours, France
[5] CHRU Tours, INSERM U930, CIC IT 806, Tours, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S398 / S398
页数：1
相关论文
共 50 条
  • [21] The in vivo molecular imaging probe [F-18]FDDNP demonstrates NSAID binding to Aβ senile plaques in Alzheimer's disease
    Agdeppa, E
    Kepe, V
    Satyamurthy, N
    Small, GW
    Cole, GM
    Barrio, JR
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S422 - S422
  • [22] Increased retention of tau PET ligand [18F]-AV1451 in Alzheimer's Disease Psychosis
    Gomar, J. J.
    Tan, G.
    Halpern, J.
    Gordon, M. L.
    Greenwald, B.
    Koppel, J.
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)
  • [23] Increased retention of tau PET ligand [18F]-AV1451 in Alzheimer’s Disease Psychosis
    J. J. Gomar
    G. Tan
    J. Halpern
    M. L. Gordon
    B. Greenwald
    J. Koppel
    Translational Psychiatry, 12
  • [24] PET imaging of early stages of Alzheimer's disease (AD) in transgenic mice with F-18 hydroxy quinoline
    Kulkarni, Padmakar
    Arora, Veera
    Chiguru, S.
    Hao, Guiyang
    Gupta, A.
    Slavine, Nikolai
    Vasdev, Neil
    Sun, Xiankai
    Antich, P.
    Bonte, Frederick
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [25] In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging
    Barrio, Jorge R.
    Small, Gary W.
    Wong, Koon-Pong
    Huang, Sung-Cheng
    Liu, Jie
    Merrill, David A.
    Giza, Christopher C.
    Fitzsimmons, Robert P.
    Omalu, Bennet
    Bailes, Julian
    Kepe, Vladimir
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (16) : E2039 - E2047
  • [26] 18F-FDG and Amyloid PET imaging in Alzheimer's Disease
    Chiaravalloti, Agostino
    Schillaci, Orazio
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 : 13 - 15
  • [27] F-18 labeled PET agents for amyloid plaque imaging
    Kung, Mei-Ping
    Zhang, W.
    Oya, S.
    Hou, C.
    Kung, H.
    NEUROIMAGE, 2006, 31 : T51 - T51
  • [28] AMYLOID AND TAU DEPOSITION IN ALZHEIMER'S DISEASE PROGRESSION USING [C-11]PIB AND [F-18]THK-5117
    Betthauser, T.
    Lao, P.
    Murali, D.
    Higgins, A.
    Barnhart, T.
    Furumoto, S.
    Okamura, N.
    Stone, C.
    Johnson, S.
    Christian, B.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 647 - 648
  • [29] Monte-Carlo Simulations for Evaluating Sensitivity of Tau Detection in [F-18]MK-6240 PET Scans of Early Stage Alzheimer's Disease
    McVea, Andrew
    Betthauser, Tobey
    Zammit, Matthew
    Tullis, Tyler
    DiFilippo, Alexandra
    Johnson, Sterling
    Christian, Bradley
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [30] PET WITH F-18 DEOXYGLUCOSE FOR PANCREATIC DISEASE
    KLEVER, P
    BARES, R
    FASS, J
    BULL, U
    SCHUMPELICK, V
    LANCET, 1992, 340 (8828): : 1158 - 1159
12345